Subgroup analysis demonstrated less evidence of a causal relationship between IL-6 and ER + BC risk (OR 1.08, 95% CI 0.95–1.22, P = 0.2312) or ER-BC risk (OR 0.97, 95% CI 0.81–1.16, P = 0.7155). This evidence concerns the gene IL6 and breast cancer.